Cargando…

1176. Experience with PCV10 Implementation in Colombia and More Severe Course of Pneumococcal Pneumonia in children: A Multicenter Study, 2008 – 2019 (Neumocolombia Network)

BACKGROUND: Pneumococcal conjugate vaccines (PCV) have decreased pneumonia in children. Colombia introduced massive vaccination with PCV10 in 2012. METHODS: Pneumococcal pneumonia cases from 10 hospitals part of an active surveillance network for invasive pneumococcal disease were included. Two peri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tobar, Ivan Felipe Gutiérrez, Londoño, Juan Pablo, Drews, Cristina Mariño, Beltran, Sandra, Castro, Aura Lucia Leal, Patiño-Niño, Jaime alberto, Alvarez-Olmos, Martha Isabel, Barreto, Rocio Barrero, Espinosa, Fabio, Suarez, Maria Alejandra, Ramos, Nicolas, Mejia, Vivian Marcela Moreno, Marin, Alejandra, Parada, Claudia Rocio Sierra, Pescador, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644179/ http://dx.doi.org/10.1093/ofid/ofab466.1369

Ejemplares similares

Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
por: Camacho Moreno, Germán, et al.
Publicado: (2020)

Changes in the incidence of acute bacterial meningitis caused by Streptococcus pneumoniae and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10
por: Farfán-Albarracín, Juan David, et al.
Publicado: (2022)

Impact of Ten-Valent Pneumococcal Conjugate Vaccine Introduction on Serotype Distribution Trends in Colombia: An Interrupted Time-Series Analysis
por: Leal, Aura Lucia, et al.
Publicado: (2017)

Efecto de las medidas preventivas durante la pandemia: más allá del SARS CoV-2
por: Leal-Castro, Aura Lucía
Publicado: (2021)

Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia
por: Castro, Aura Lucia Leal, et al.
Publicado: (2022)

Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report
por: Saavedra, Sandra Yamile, et al.
Publicado: (2014)

Community-associated Methicillin-resistant Staphylococcus aureus, Colombia
por: Alvarez, Carlos A., et al.
Publicado: (2006)

Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles
por: Cortes, Jorge Alberto, et al.
Publicado: (2013)

Infections in patients with adverse reactions to the use of unknown modeling substances for soft tissue enhancement in Cali, Colombia
por: Bonilla Moncada, Jennifer, et al.
Publicado: (2023)

Assessment of Ambivalent Sexism in University Students in Colombia and Spain: A Comparative Analysis
por: Rodríguez-Burbano, Aura Yolima, et al.
Publicado: (2021)

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
por: Galanis, Ilias, et al.
Publicado: (2016)

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C
por: Shi, Yaru, et al.
Publicado: (2023)

The Prevalence and Genetic Diversity of PCV3 and PCV2 in Colombia and PCV4 Survey during 2015–2016 and 2018–2019
por: Vargas-Bermudez, Diana S., et al.
Publicado: (2022)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

1180. Comparing Changes in Pneumococcal Meningitis Incidence to all Invasive Pneumococcal Disease Following Introduction of PCV10 and PCV13: The PSERENADE Project
por: Yang, Yangyupei, et al.
Publicado: (2021)

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
por: Roca, Anna, et al.
Publicado: (2015)

Reflections on Afro-descendant origin and the outcome of dengue fever cases in Colombia
por: Rengifo, Aura Caterine, et al.
Publicado: (2017)

1429. Emergence of Multidrug-resistant Serotype 24 Among Children Under 2 Years Old With Invasive Pneumococcal Disease After the Introduction of PCV13 in Argentina
por: Gagetti, Paula, et al.
Publicado: (2018)

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
por: van der Linden, Mark, et al.
Publicado: (2016)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced
por: Chang, Qiuzhi, et al.
Publicado: (2015)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

1735. Impact of Children Universal Pneumococcal Vaccination (PCV7v/PCV13v) on Pneumococcal Invasive Disease Hospitalizations in a Private General Hospital, Uruguay
por: Sanchez-Varela, Mercecedes, et al.
Publicado: (2023)

1176. Quality of Life of Previously Healthy Subjects following Cryptococcal Meningoencephalitis
por: Dean, Owen, et al.
Publicado: (2020)

An epidemiological and molecular study regarding the spread of vancomycin-resistant Enterococcus faecium in a teaching hospital in Bogotá, Colombia 2016
por: Corredor, Nancy Carolina, et al.
Publicado: (2019)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

Cost-effectiveness of a Dengue Vector Control Intervention in Colombia
por: Taborda, Alejandra, et al.
Publicado: (2022)

Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines
por: Hadjipanayis, Adamos, et al.
Publicado: (2016)

Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults
por: Humphreys, Hilary, et al.
Publicado: (2023)

1104 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired Pneumonia Immunization Trial In Adults (CAPiTA)
por: Van Deursen, Anna M.M., et al.
Publicado: (2014)

1628. Clinical, Epidemiological and Microbiological Characterization of Invasive Streptococcus pneumoniae Disease in Hospitalized Adults from 5 Tertiary Hospitals in Bogotá, Colombia: A Descriptive Study
por: Lucia Leal Castro, Aura, et al.
Publicado: (2019)

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
por: Gladstone, Rebecca A., et al.
Publicado: (2015)

Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13
por: Mitchell, Patrick K., et al.
Publicado: (2019)

Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 – 2015
por: Nhantumbo, Aquino Albino, et al.
Publicado: (2017)

Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2020)

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
por: Izquierdo, C., et al.
Publicado: (2020)

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
por: Savrasova, Larisa, et al.
Publicado: (2021)

Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
por: Kim, Hyunjung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rcdg4f3r6i01n0fqab4jd6dr1l